DUBLIN--(BUSINESS WIRE)--The "Global Biopharmaceutical Analytical Testing Services Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.
The global biopharmaceutical analytical testing services market is projected to grow at a CAGR of 8.98% during the period 2018-2022.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is the rise in investment in R&D. The global expenditure on R&D is increasing constantly and it increased by 3.21% in 2016. The rise in the number of testing and research facilities, particularly in the field of pharmaceuticals will rise the demand for analytical testing services to develop biopharmaceutical drugs.
According to the report, one of the major drivers for this market is the increase in demand for mAbs. The global mAbs market is growing because mAbs are used for immunotherapy to stimulate immune responses to treat diseases. R&D for antibodies against diseases like Ebola, and cancers is carried out.
Further, the report states that one of the major factors hindering the growth of this market is the shortage of skilled professionals. The lack of required skills leads to a high degree of non-compliance among laboratory professionals.
Key Vendors
- Catalent
- Charles River
- Eurofins Scientific
- Merck KGaA
- SGS
Key Topics Covered
01. Executive Summary
02. Scope of the Report
03. Research Methodology
04. Market Landscape
05. Market Sizing
06. Five Forces Analysis
07. Customer Landscape
08. Market Segmentation by End-User
09. Regional Landscape
10. Decision Framework
11. Drivers and Challenges
12. Market Trends
13. Vendor Landscape
14. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/27kv8h/biopharmaceutical?w=4
